mk 0663 has been researched along with Allodynia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amat, M; Beleta, J; Cárdenas, A; Caturla, F; Crespo, MI; Godessart, N; Jiménez, JM; Ryder, H; Soca, L | 1 |
| Boulet, L; Brideau, C; Claveau, D; Côté, B; Ducharme, Y; Ethier, D; Frenette, R; Friesen, RW; Gagnon, M; Giroux, A; Guay, J; Guiral, S; Mancini, J; Martins, E; Massé, F; Méthot, N; Riendeau, D; Rubin, J; Xu, D; Yu, H | 1 |
| Benson, HAE; Moss, P; Will, R; Wright, A | 1 |
| Conzen, P; Fleckenstein, J; Hatz, R; Heindl, B; Irnich, D; Kramer, S; Lang, PM; Lehmeyer, L; Mussack, T; Offenbächer, M; Plischke, H; Schober, G; Siebeck, M | 1 |
| Boulet, J; Gottshall, S; Harrison, J; Mark, L; Pearson, M; Walker, K; Whiteside, GT | 1 |
| Kulkarni, SK; Patil, CS; Singh, VP | 1 |
2 trial(s) available for mk 0663 and Allodynia
| Article | Year |
|---|---|
Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial.
Topics: Aged; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Hyperalgesia; Locomotion; Male; Middle Aged; Neuralgia; Osteoarthritis, Knee; Pain Measurement; Pyridines; Sulfones | 2017 |
Etoricoxib--preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy--design and protocols.
Topics: Analgesia; Analgesia, Patient-Controlled; Analgesics; Aryl Hydrocarbon Hydroxylases; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Administration Schedule; Etoricoxib; Germany; Humans; Hyperalgesia; Laparotomy; Morphine; Narcotics; Pain Measurement; Pain Threshold; Pain, Postoperative; Placebo Effect; Polymorphism, Genetic; Pyridines; Research Design; Sulfones; Thoracotomy; Time Factors; Treatment Outcome | 2010 |
4 other study(ies) available for mk 0663 and Allodynia
| Article | Year |
|---|---|
Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Blood Proteins; Cyclooxygenase 2; Humans; Hyperalgesia; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrans; Rats; Rats, Wistar; Structure-Activity Relationship | 2004 |
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.
Topics: Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Drug Design; Guinea Pigs; Humans; Hyperalgesia; Imidazoles; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Molecular Structure; Phenanthrenes; Prostaglandin-E Synthases; Rats; Structure-Activity Relationship | 2007 |
Pharmacological characterisation of a rat model of incisional pain.
Topics: Amines; Analgesics; Animals; Behavior, Animal; Celecoxib; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Etoricoxib; Foot; Gabapentin; gamma-Aminobutyric Acid; Hindlimb; Hyperalgesia; Indomethacin; Male; Morphine; Muscle, Skeletal; Naproxen; Nociceptors; Pain Threshold; Pain, Postoperative; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sulfonamides; Sulfones; Time Factors; Weight-Bearing | 2004 |
Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats.
Topics: Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Etoricoxib; Female; Hyperalgesia; Pain Threshold; Pyridines; Rats; Rats, Wistar; Spinal Cord Injuries; Sulfones; Tramadol | 2006 |